While the precise mechanisms by which tau pathology contributes to AD pathogenesis are not fully understood, recent studies have implicated an interaction between tau and the ribosome as an early event in the disease’s progression (Kavanagh et al., 2022). This evidence concerns the gene MAPT and Alzheimer disease.